Medicine breaks roughly into quarters — medical expertise/physicians (~25%, going toward zero cost), pharmaceuticals (~25%, transformed by AI drug design where the key gain is raising the <5% probability of FDA approval from a lead candidate), diagnostics/imaging (~25%, where the cost is the technician not the machine, addressable by 'self-driving' MRI/ultrasound), and in-hospital care (~25%).